LumiMeds review
A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, and both prices are 'From' starting prices rather than a guaranteed working-dose rate.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
LumiMeds at a glance
- Semaglutide
- From $99/mo
- Tirzepatide
- From $183/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored LumiMeds
Each score comes out of LumiMeds's published pricing, disclosures and oversight, and the six combine into the 65/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair value once you read past any teaser rate or plan structure.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.lumimeds.com
$99 and $183, both 'from' figures across all fifty states, so neither is guaranteed at a working dose. LumiMeds also holds FDA warning letter 716510, issued September 2025 — disclosed here rather than left for you to find on your own.
What to expect when you sign up
We walked LumiMeds's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage lists 'From $X/month' starting prices for semaglutide, tirzepatide, and NAD+ directly, before any intake
- 2A BMI/weight-loss projection tool runs on the homepage using self-reported patient outcome data, not a clinical guarantee
- 3A named Medical Director (Dr. Teresa Walsh, M.D.) is credited, stated as 'Licensed in all 50 states'
- 4States 'No membership required' on every plan tile
What we noticed
- A named, credentialed Medical Director with explicit all-50-state licensure is a stronger trust signal than most long-tail providers in this round
- 'From $X/month' framing means the exact price at a working dose isn't guaranteed by the homepage number alone
- HSA/FSA accepted, and Klarna financing is offered on select plans
- No named compounding pharmacy, and no statement on video-visit requirements
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99 | Starting priceListed as 'From $99/month' — no membership required; exact price scales with dose. |
| Compounded tirzepatide | $183 | Starting priceListed as 'From $183/month' — no membership required; exact price scales with dose. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from LumiMeds's public disclosures at last review and change often; confirm the current number on LumiMeds's own site.
What we like
- Named Medical Director (Dr. Teresa Walsh, M.D.) stated as licensed in all 50 states
- No membership required on any plan
- HSA/FSA accepted, plus Klarna financing on select plans
- Also offers NAD+ injectable therapy on the same platform
The caveats
- FDA warning letter (#716510, issued 2025-09-09) cites Lumimeds for describing its compounded semaglutide/tirzepatide as equivalent to FDA-approved brand medication — compounded drugs are not FDA-approved, and the letter found the comparison misleading
- Both prices are framed as 'From' — the exact cost at a working dose isn't guaranteed by the homepage figure
- No named compounding pharmacy found on the pages checked
- No published time-to-first-dose or statement on whether a video visit is required
- No brand-name (FDA-approved) option and no oral form
LumiMeds for mothers: our verdict
A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, and both prices are 'From' starting prices rather than a guaranteed working-dose rate. It runs about $99/month — toward the affordable end of what we track.
We weigh LumiMeds the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What LumiMeds actually costs
- Compounded semaglutide — Starting price: $99/mo
- Compounded tirzepatide — Starting price: $183/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications LumiMeds prescribes
LumiMeds prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where LumiMeds fits — and where it doesn't — for mothers
Worth it if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
LumiMeds is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want a named, all-50-state-licensed Medical Director behind the program and are comfortable confirming the real working-dose price at intake.
Alternatives to LumiMeds
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing LumiMeds
Head-to-head & alternatives
LumiMeds, answered
- How much does LumiMeds cost?
- When we last checked, the cheapest ongoing compounded price at LumiMeds was around $99 a month: From $99/mo for semaglutide and From $183/mo for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is LumiMeds safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to LumiMeds as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does LumiMeds offer both semaglutide and tirzepatide?
- Yes — LumiMeds offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does LumiMeds rank for mothers?
- LumiMeds takes 65/100 in our Editors' Rating, placing it #74. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect LumiMeds's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.